We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
GenScript Sars-Cov-2 Spike Glycoprotein-Omicron-90% Purity; 2vials(25ug/peptide)
List Price $1,002.00 Your Price $1,002.00
GenScript Sars-Cov-2 Spike Glycoprotein-Omicron-90% Purity2vials(25ug/Peptide) - GSCRPT (Additional S&H or Hazmat Fees May Apply)
NETA PART: GSCRPT-RP30219
MFG.PART: RP30219
UNSPSC: 12352202
Manufacturer: GenScript USA Inc
Overview
| Description | This pool isdelivered in two sub-pools of 158 & 157 peptides derived from a peptidescan (15mers with 11 aa overlap) through the entire Spike glycoprotein ofSARS-CoV-2 B.1.1.529 (Severe Acute Respiratory Syndrome-related coronavirus 2,Lineage B.1.1.529, South Africa, Omicron) covering the following mutations:A67V, H69-, V70-, T95I, G142-, V143-, Y144-, Y145D, N211-, L212I, "EPE"insertion between 214R and 215D, G339D, S371L, S373P, S375F, K417N, N440K,G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G,H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. |
| Sequence | MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS NVTWFHVISGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIVNN ATNVVIKVCEFQFCNDPFLDHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGN FKNLREFVFKNIDGYFKIYSKHTPIIVREPEDLPQGFSALEPLVDLPIGINITRFQTLLA LHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTL KSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVA DYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNY KLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGV AGFNCYFPLRSYSFRPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNF NGLKGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTN TSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEYVNNSYECD IPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVT TEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFA QVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGD IAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMA YRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNHNAQALNTLV KQLSSKFGAISSVLNDIFSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASAN LAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICH DGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQP ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL GKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEP VLKGVKLHYT |
Properties
| Source | SevereAcute Respiratory Syndrome-related coronavirus 2 (Spike B.1.1.529) Spikeglycoprotein (covering the following mutations: A67V, H69-, V70-, T95I, G142-, V143-, Y144-, Y145D, N211-, L212I,"EPE" insertion between 214R and 215D, G339D, S371L, S373P, S375F,K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H,T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F). |
| Gene ID | S |
| Length | 1270 aa |
| Purity | 90% by RP-HPLC (Majorpeak by ESI-MS is guaranteed to be peptide of interest - determined at 220 nmfor each individual peptide). |
| Solubility | Dissolve in a minimum amount of pure DMSO (approx. 50 µl) and dilute with PBS buffer to the final concentration. Please note that the final concentration of DMSO must be below 1 % (v/v) to avoid toxicity in the biological system. |
| Form | Lyophilized |
| Storage | Store at -20°C. |
| Note | Thepeptides of this product are supplied as trifluoroacetate salts. |
| SKU | GSCRPT-RP30219 |
|---|---|
| Supplier Part Number | RP30219 |
| UM | EA |
| UNSPSC | 12352202 |
| Manufacturer | GenScript USA Inc |
| ProductLine | GSCRPT |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 7 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |